Delivery Order SPE2DB22D1106-SPE2DB25FEJL1

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,417.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Alvimopan 12 mg capsules. The contract is a Firm Fixed Price Delivery Order, with a performance period extending through May 2025. AmerisourceBergen, the prime contractor, has not been designated a set-aside contract. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $19,979.49 firm fixed price delivery order is for the supply of 4,566,047,909 units of the medication Alvimopan 12 MG Capsule UD 30S. The contract has an ultimate completion date of October 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,547.61 firm fixed-price delivery order is for the supply of the medication Alvimopan 12 mg capsules. The award is not designated as a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,080.46 firm fixed-price delivery order is for the provision of 4,564,898,629 units of the prescription medication Alvimopan 12 mg capsules. The award does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of 4,562,052,287 units of the pharmaceutical product Alvimopan 12 mg capsules. The $10,222.38 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through September 6, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen is a major...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $37,093.46 firm fixed-price delivery order is for the supply of 4,565,218 units of the prescription drug Alvimopan 12 mg capsules. The contract has a period of performance through July 22, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FB8A3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,615.12 firm fixed-price delivery order is for the supply of the medication Alvimopan 12 mg capsules, with a completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,921.32, is a delivery order for the supply of ALVIMOPAN 12 MG CAPSULE UD 30S, a medication used in healthcare settings. The contract has an ultimate completion date of July 2, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,042.46, is a Firm Fixed Price delivery order for the supply of Alvimopan 12 mg capsules. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, to provide ALVIMOPAN 12 MG CAPSULE UD 30S. The contract has a potential value of $4,937.71 and a completion date of January 30, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEJL1
    Delivery Order

This federal contract award, valued at $4,994.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,966,166 units of the medication Alvimopan 12 mg capsule, with a performance period that extends through April 21, 2025.

This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, designated as SPE2DX, which has a ceiling value of $999,999,999.00. The IDC provides a comprehensive global pharmaceutical support vehicle for the DLA Troop Support Medical, with a performance period through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any major subcontractors.

Generated 7/18/25, 9:56 AM